Identification of functionally relevant lysine residues that modulate human farnesoid X receptor activations

Molecular Pharmacology

Volumn 83, Issue 5, 2013, Pages 1078-1086

  Sun, An Qiang ^a   Luo, Yuhuan ^a   Backos, Donald S ^b   Xu, Shuhua ^a   Balasubramaniyan, Natarajan ^a   Reigan, Philip ^b   Suchy, Frederick J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FARNESOID X RECEPTOR; LYSINE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE ACTIVATION; GENE LOCATION; GENETIC ASSOCIATION; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN DNA INTERACTION;

AMINO ACID SEQUENCE; ARGININE; ATP-BINDING CASSETTE TRANSPORTERS; CACO-2 CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE INHIBITORS; HUMANS; LIGANDS; LYSINE; METHYLTRANSFERASES; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOID X RECEPTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84876554634     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.084772     Document Type: Article

References (32)

1. Balasubramaniyan N, Ananthanarayanan M, and Suchy FJ (2012) Direct methylation of FXR by Set7/9, a lysine methyltransferase, regulates the expression of FXR target genes. Am J Physiol Gastrointest Liver Physiol 302:G937-G947.
2. Balasubramaniyan N, Shahid M, Suchy FJ, and Ananthanarayanan M (2005) Multiple mechanisms of ontogenic regulation of nuclear receptors during rat liver development. Am J Physiol Gastrointest Liver Physiol 288:G251-G260. (Pubitemid 40129576)
3. Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP, and Rastinejad F (2008) Structure of the intact PPAR-gamma-RXR-nuclear receptor complex on DNA. Nature 456:350-356.
4. Couture JF, Collazo E, Hauk G, and Trievel RC (2006) Structural basis for the methylation site specificity of SET7/9. Nat Struct Mol Biol 13:140-146. (Pubitemid 43214717)
5. Del Rizzo PA and Trievel RC (2011) Substrate and product specificities of SET domain methyltransferases. Epigenetics 6:1059-1067.
6. Downes M, Verdecia MA, Roecker AJ, Hughes R, Hogenesch JB, Kast-Woelbern HR, Bowman ME, Ferrer JL, Anisfeld AM, and Edwards PA et al. (2003) A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell 11: 1079-1092. (Pubitemid 36566328)
7. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, Pieper U, and Sali A (2006) Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics 15:5.6.1-5.6.30.
8. Fang S, Tsang S, Jones R, Ponugoti B, Yoon H, Wu SY, Chiang CM, Willson TM, and Kemper JK (2008) The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP. J Biol Chem 283:35086-35095.
9. Feig M, Onufriev A, Lee MS, Im W, Case DA, and Brooks CL, 3rd (2004) Performance comparison of generalized Born and Poisson methods in the calculation of electrostatic solvation energies for protein structures. J Comput Chem 25:265-284.
10. Fu M, Wang C, Zhang X, and Pestell RG (2004) Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem Pharmacol 68:1199-1208. (Pubitemid 39094285)
11. Grienke U, Mihály-Bison J, Schuster D, Afonyushkin T, Binder M, Guan SH, Cheng CR, Wolber G, Stuppner H, and Guo DA et al. (2011) Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes fromGanoderma lucidum. Bioorg Med Chem 19:6779-6791.
12. Hollman DA, Milona A, van Erpecum KJ, and van Mil SW (2012) Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms. Biochim Biophys Acta 1821:1443-1452.
13. Hung HL, Lau J, Kim AY, Weiss MJ, and Blobel GA (1999) CREB-binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites. Mol Cell Biol 19:3496-3505. (Pubitemid 29193809)
14. Kemper JK (2011) Regulation of FXR transcriptional activity in health and disease: Emerging roles of FXR cofactors and post-translational modifications. Biochim Biophys Acta 1812:842-850.
15. Kemper JK, Xiao Z, Ponugoti B, Miao J, Fang S, Kanamaluru D, Tsang S, Wu SY, Chiang CM, and Veenstra TD (2009) FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab 10:392-404.
16. Kimura A, Matsubara K, and Horikoshi M (2005) A decade of histone acetylation: Marking eukaryotic chromosomes with specific codes. J Biochem 138: 647-662. (Pubitemid 43258858)
17. Lee H, Zhang Y, Lee FY, Nelson SF, Gonzalez FJ, and Edwards PA (2006) FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine. J Lipid Res 47:201-214. (Pubitemid 43107463)
18. Li X, Zhang S, Blander G, Tse JG, Krieger M, and Guarente L (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 28: 91-106. (Pubitemid 47531974)
19. Lu X and Hansen JC (2003) Revisiting the structure and functions of the linker histone C-terminal tail domain. Biochem Cell Biol 81:173-176. (Pubitemid 37076239)
20. Modica S, Gadaleta RM, and Moschetta A (2010) Deciphering the nuclear bile acid receptor FXR paradigm. Nucl Recept Signal 8:e005.
21. Shen MY and Sali A (2006) Statistical potential for assessment and prediction of protein structures. Protein Sci 15:2507-2524. (Pubitemid 44771688)
22. Soisson SM, Parthasarathy G, Adams AD, Sahoo S, Sitlani A, Sparrow C, Cui J, and Becker JW (2008) Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation. Proc Natl Acad Sci USA 105: 5337-5342. (Pubitemid 351753864)
23. Soutoglou E, Katrakili N, and Talianidis I (2000) Acetylation regulates transcription factor activity at multiple levels. Mol Cell 5:745-751.
24. Suchy FJ and Ananthanarayanan M (2006) Bile salt excretory pump: Biology and pathobiology. J Pediatr Gastroenterol Nutr 43 (Suppl 1):S10-S16. (Pubitemid 44014972)
25. Sumimoto H, Kamakura S, and Ito T (2007) Structure and function of the PB1 domain, a protein interaction module conserved in animals, fungi, amoebas, and plants. Sci STKE 2007:re6.
26. Sun AQ, Balasubramaniyan N, Chen H, Shahid M, and Suchy FJ (2006) Identification of functionally relevant residues of the rat ileal apical sodium-dependent bile acid cotransporter. J Biol Chem 281:16410-16418.
27. Sun AQ, Balasubramaniyan N, Liu CJ, Shahid M, and Suchy FJ (2004) Association of the 16-kDa subunit c of vacuolar proton pump with the ileal Na1-dependent bile acid transporter: Protein-protein interaction and intracellular trafficking. J Biol Chem 279:16295-16300. (Pubitemid 38509324)
28. Sun AQ, Balasubramaniyan N, Xu K, Liu CJ, Ponamgi VM, Liu H, and Suchy FJ (2007) Protein-protein interactions and membrane localization of the human organic solute transporter. Am J Physiol Gastrointest Liver Physiol 292:G1586-G1593. (Pubitemid 47080612)
29. Vaz B and de Lera AR (2012) Advances in drug design with RXR modulators. Expert Opin Drug Discov 7:1003-1016.
30. Xiao B, Jing C, Wilson JR, Walker PA, Vasisht N, Kelly G, Howell S, Taylor IA, Blackburn GM, and Gamblin SJ (2003) Structure and catalytic mechanism of the human histone methyltransferase SET7/9. Nature 421:652-656. (Pubitemid 36227675)
31. Zhang W and Bieker JJ (1998) Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc Natl Acad Sci USA 95:9855-9860.
32. Zhang Y and Edwards PA (2008) FXR signaling in metabolic disease. FEBS Lett 582: 10-18. (Pubitemid 350297240)